niacinamide has been researched along with Flushing in 8 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Flushing: A transient reddening of the face that may be due to fever, certain drugs, exertion, or stress.
Excerpt | Relevance | Reference |
---|---|---|
"Niacin has established its role in the prevention of coronary artery disease." | 5.34 | Case reports: new onset flushing due to unauthorized substitution of niacin for nicotinamide. ( Bechtel, M; Kademian, M; Zirwas, M, 2007) |
" However, niacin can cause flushing and niacinamide probably cause thrombocytopenia." | 4.90 | Benefits and harm of niacin and its analog for renal dialysis patients: a systematic review and meta-analysis. ( Feng, L; He, YM; Huo, DM; Liao, YH; Yang, ZH, 2014) |
" The results suggest that nicotinic acid in a dosage of 16." | 2.74 | Investigation of niacin on parameters of metabolism in a physiologic dose: randomized, double-blind clinical trial with three different dosages. ( Reimann, J; Schön, C; Schweikart, J, 2009) |
" Since both drugs are extensively metabolized, this study investigated the bioavailability and pharmacokinetics of their co-administration following single-dose administration." | 2.73 | The comparative bioavailability of an extended-release niacin and lovastatin fixed dose combination tablet versus extended-release niacin tablet, lovastatin tablet and a combination of extended-release niacin tablet and lovastatin tablet. ( Cefali, E; Menon, R; Tolbert, D, 2007) |
"Niacin has been used for decades in the treatment of patients with disturbed lipid and lipoprotein metabolism, this being the main cause of atherosclerotic changes in cardiovascular diseases." | 2.44 | [Niacin in therapy]. ( Bryła, J; Nagalski, A, 2007) |
"Niacin has established its role in the prevention of coronary artery disease." | 1.34 | Case reports: new onset flushing due to unauthorized substitution of niacin for nicotinamide. ( Bechtel, M; Kademian, M; Zirwas, M, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
He, YM | 1 |
Feng, L | 1 |
Huo, DM | 1 |
Yang, ZH | 1 |
Liao, YH | 1 |
Schweikart, J | 1 |
Reimann, J | 1 |
Schön, C | 1 |
Nagalski, A | 1 |
Bryła, J | 1 |
Menon, R | 1 |
Tolbert, D | 1 |
Cefali, E | 1 |
Kademian, M | 1 |
Bechtel, M | 1 |
Zirwas, M | 1 |
Subissi, A | 1 |
Bachi, M | 1 |
Brunori, P | 1 |
Dallimore, KJ | 1 |
Walter, AA | 1 |
2 reviews available for niacinamide and Flushing
Article | Year |
---|---|
Benefits and harm of niacin and its analog for renal dialysis patients: a systematic review and meta-analysis.
Topics: Flushing; Humans; Lipoproteins, HDL; Niacin; Niacinamide; Phosphorus; Randomized Controlled Trials a | 2014 |
[Niacin in therapy].
Topics: Adipocytes; Adiponectin; Animals; Cholesterol, HDL; Delayed-Action Preparations; Flushing; Humans; H | 2007 |
2 trials available for niacinamide and Flushing
Article | Year |
---|---|
Investigation of niacin on parameters of metabolism in a physiologic dose: randomized, double-blind clinical trial with three different dosages.
Topics: Adult; Blood Pressure; Body Mass Index; Cross-Over Studies; Diet; Dietary Supplements; Double-Blind | 2009 |
The comparative bioavailability of an extended-release niacin and lovastatin fixed dose combination tablet versus extended-release niacin tablet, lovastatin tablet and a combination of extended-release niacin tablet and lovastatin tablet.
Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Biological Availability; Cross-Over Studies; D | 2007 |
4 other studies available for niacinamide and Flushing
Article | Year |
---|---|
Case reports: new onset flushing due to unauthorized substitution of niacin for nicotinamide.
Topics: Anti-Inflammatory Agents; Drug Prescriptions; Female; Flushing; Humans; Middle Aged; Niacin; Niacina | 2007 |
Some cardiovascular effects of LG 13979: comparison with nicotinic acid and other nicotinic acid derivatives.
Topics: Animals; Blood Pressure; Female; Flushing; Guinea Pigs; Heart Rate; Hemodynamics; Male; Niacin; Niac | 1983 |
Response to the article, 'Pellagra in a woman using alternative remedies'.
Topics: Administration, Oral; Complementary Therapies; Female; Flushing; Humans; Niacin; Niacinamide; Pellag | 1998 |
Megavitamin and megamineral therapy in childhood.
Topics: Flushing; Humans; Hypercholesterolemia; Niacin; Niacinamide | 1992 |